CHICAGO, IL—Chlorthalidone does not reduce major adverse cardiovascular events compared hydrochlorothiazide in older, predominantly male military veterans with hypertension, according to the ...

Patients receiving chlorthalidone had lower rates of major cardiovascular (CV) events and noncancer-related deaths vs those receiving hydrochlorothiazide. Currently, most US-based thiazide ...

Nitin Khosla, MD, and colleagues at Rush University Medical Center (Chicago, Illinois), reviewed 2000 charts from patients referred to the University's Hypertension/Clinical Research Center. All of ...

Chlorthalidone does not differ significantly in kidney outcomes from hydrochlorothiazide, but it is associated with a higher risk for hypokalemia. Chlorthalidone is not superior to hydrochlorothiazide ...

WEST CONSHOHOCKEN, Pa., May 6, 2025 /PRNewswire/ -- PRM Pharma, LLC today announced the U.S. Food and Drug Administration (FDA) approval of HemiClor (12.5 mg chlorthalidone) tablets for the treatment ...

High blood pressure is one of the most common health problems in the world. Millions of people live with it every day, and ...

blood pressure gauges In a study of patients with stage 4 chronic kidney disease and poorly controlled blood pressure, chlorthalidone significantly decreased systolic blood pressure compared with ...

HemiClor is expected to be available in pharmacies starting in May 2025. The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the treatment of ...

BOSTON -- In people with hypertension, a history of kidney stones may inform the choice of diuretic for stone prevention, according to a secondary analysis of the Diuretic Comparison Project. Among ...